CERT has 36-month beta value of 1.64. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CERT is 120.99M, and currently, short sellers hold a 4.89% ratio of that float. The average trading volume of CERT on April 02, 2025 was 1.32M shares.
CERT) stock’s latest price update
Certara Inc (NASDAQ: CERT)’s stock price has soared by 2.62 in relation to previous closing price of 9.87. Nevertheless, the company has seen a loss of -0.21% in its stock price over the last five trading days. globenewswire.com reported 2025-04-01 that RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has released a new version of the Simcyp™ Simulator for physiologically-based pharmacokinetic (PBPK) modeling.
CERT’s Market Performance
Certara Inc (CERT) has experienced a -0.21% fall in stock performance for the past week, with a -14.53% drop in the past month, and a -3.91% drop in the past quarter. The volatility ratio for the week is 4.49%, and the volatility levels for the past 30 days are at 4.88% for CERT. The simple moving average for the last 20 days is -4.86% for CERT’s stock, with a simple moving average of -16.53% for the last 200 days.
Analysts’ Opinion of CERT
Many brokerage firms have already submitted their reports for CERT stocks, with TD Cowen repeating the rating for CERT by listing it as a “Buy.” The predicted price for CERT in the upcoming period, according to TD Cowen is $16 based on the research report published on February 27, 2025 of the current year 2025.
UBS, on the other hand, stated in their research note that they expect to see CERT reach a price target of $16. The rating they have provided for CERT stocks is “Buy” according to the report published on September 27th, 2024.
KeyBanc Capital Markets gave a rating of “Overweight” to CERT, setting the target price at $23 in the report published on April 10th of the previous year.
CERT Trading at -17.39% from the 50-Day Moving Average
After a stumble in the market that brought CERT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.19% of loss for the given period.
Volatility was left at 4.88%, however, over the last 30 days, the volatility rate increased by 4.49%, as shares sank -15.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.87% lower at present.
During the last 5 trading sessions, CERT fell by -0.44%, which changed the moving average for the period of 200-days by -30.98% in comparison to the 20-day moving average, which settled at $10.64. In addition, Certara Inc saw -4.90% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CERT starting from SMITH PATRICK F, who proposed sale 20,142 shares at the price of $9.73 back on Apr 02 ’25. After this action, SMITH PATRICK F now owns shares of Certara Inc, valued at $195,982 using the latest closing price.
SMITH PATRICK F, the PRESIDENT, DRUG DEV SOLUTIONS of Certara Inc, sale 5,409 shares at $11.03 during a trade that took place back on Oct 07 ’24, which means that SMITH PATRICK F is holding 50,091 shares at $59,661 based on the most recent closing price.
Stock Fundamentals for CERT
Current profitability levels for the company are sitting at:
- 0.02 for the present operating margin
- 0.53 for the gross margin
The net margin for Certara Inc stands at -0.03. The total capital return value is set at 0.0. Equity return is now at value -1.14, with -0.77 for asset returns.
Based on Certara Inc (CERT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 5.68. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 0.28.
Currently, EBITDA for the company is -36.71 million with net debt to EBITDA at -3.6. When we switch over and look at the enterprise to sales, we see a ratio of 3.81. The receivables turnover for the company is 3.77for trailing twelve months and the total asset turnover is 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.13.
Conclusion
To put it simply, Certara Inc (CERT) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
